National Institute of Health and Care Excellence (NICE) reports women should be offered hormone replacement therapy (HRT) to fight the menopause as its benefits have far outweighed the associated risks despite it has a possible link to cancer.
According to NICE, their new guidelines for HRT were not to hike the number of women opting for the therapy, but to give them an option to consider it. It is an effort to help women not to suffer in silence.
Cancer Research says in every 1,000 women in UK about one extra ovarian cancer case is seen who are above the age 50 and has used any type of HRT.
It reports further about six breast cancer cases are seen in every 1,000 women in UK who used oestrogen-onlyprogestogen HRT.
NICE has urged doctors to offer the therapy to up to 400,000 women suffering from menopause with most severe symptoms such as extreme tiredness, mood swings and hot flushes.
In 2003 a finding in the UK studying one million patients showed the HRT significantly raised breast cancer risk and thereafter subsequently dying.
The study led to reduction from 36 percent to 10 percent to number of women on HRT over the next few years. However, NICE said their research has found the risks to be very low and has greatly outweighed by benefits.
Contradicting statement comes from Professor Klim McPherson, who is an expert in the study of disease at Oxford University. She said if the numbers of women undergoing the therapy goes back to the level that was in 2002, the breast and ovarian cancer cases may go up by about 7,000.